drug

IPS

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Fraser Health
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

2
Occupational Recovery After First Episode Psychosis
NCT03317132—Completed
Motivational Interviewing to Improve Work Outcomes in Schizophrenia
NCT00261716Phase 3Completed

KOLs & investigators

2
Shirley M. Glynn, PhDKOL score 5
David H Erickson, PhDKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Fraser Health
company
trial
Occupational Recovery After First Episode Psychosis
NA
trial
Motivational Interviewing to Improve Work Outcomes in Schizophrenia
PHASE3
trial
indication
Schizophrenia
indication
Psychosis
indication
Schizophrenia
indication
Psychotic Disorders
indication
KOL
Shirley M. Glynn, PhD
KOL score 5
person
David H Erickson, PhD
KOL score 5
person